Left atrial appendage function determined by transesophageal echocardiography in patients with rheumatic mitral valve disease

Juey Jen Hwang, Yi Heng Li, Jer Ming Lin, Tzong Luen Wang, Kou Gi Shyu, Yu Lin Ko, Jiunn Lee Lin, Jin Jer Chen, Peiliang Kuan, Wen Pin Lien

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Left atrial thrombi have been considered to be the major source of systemic arterial embolization in patients with rheumatic mitral valve disease. Almost half of the left atrial thrombi are found in the left atrial appendage (LAA). To investigate LAA size and LAA contractile function in patients with rheumatic mitral valve disease, transesophageal echocardiographic and Doppler studies were performed in 61 patients. Among them, 46 patients were in atrial fibrillation (group 1), while the other 15 were in sinus rhythm (group 2). Thirty-six patients with nonrheumatic atrial fibrillation were chosen as control to group 1. Another 22 patients with various cardiovascular diseases and sinus rhythm served as control to group 2. When compared to the patients with nonrheumatic atrial fibrillation (control group), group 1 patients tended to have a larger LAA maximal area (9.7 ± 5.2 vs. 5.9 ± 2.8 cm2; p < 0.001). LAA ejection fraction and LAA peak emptying velocity were also lower. A significantly higher incidence of LAA spontaneous echo contrast (SEC) and thrombus formation was also found in these patients. Group 2 patients were also found to have a larger LAA maximal area when compared to the control group (8.8 ± 3.7 vs. 5.2 ± 3.0 cm2; p < 0.001). LAA ejection fraction and LAA peak emptying velocity were lower in this group, too. A higher incidence of LAA SEC formation was found in these patients with rheumatic mitral valve disease (4/15 vs. 0/22; p = 0.021). There was no significant difference, however, in LAA thrombus formation between group 2 and its control group (1/15 vs. 1/22; p = NS). Thus, patients with rheumatic mitral valve disease tend to have larger LAA size and poorer LAA contractile function. These promote the formation of LAA SEC and thrombus, especially when the patients have atrial fibrillation. Whether the poor LAA function predisposes these patients to future systemic arterial embolization still needs further investigation.

Original languageEnglish
Pages (from-to)121-128
Number of pages8
JournalCardiology (Switzerland)
Volume85
Issue number2
DOIs
Publication statusPublished - Jan 1 1994
Externally publishedYes

Fingerprint

Left Atrial Function
Atrial Appendage
Transesophageal Echocardiography
Mitral Valve
Thrombosis
Atrial Fibrillation
Control Groups

Keywords

  • Left atrial appendage function
  • Rheumatic mitral valve disease
  • Transesophageal echocardiography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Cite this

Left atrial appendage function determined by transesophageal echocardiography in patients with rheumatic mitral valve disease. / Hwang, Juey Jen; Li, Yi Heng; Lin, Jer Ming; Wang, Tzong Luen; Shyu, Kou Gi; Ko, Yu Lin; Lin, Jiunn Lee; Chen, Jin Jer; Kuan, Peiliang; Lien, Wen Pin.

In: Cardiology (Switzerland), Vol. 85, No. 2, 01.01.1994, p. 121-128.

Research output: Contribution to journalArticle

Hwang, Juey Jen ; Li, Yi Heng ; Lin, Jer Ming ; Wang, Tzong Luen ; Shyu, Kou Gi ; Ko, Yu Lin ; Lin, Jiunn Lee ; Chen, Jin Jer ; Kuan, Peiliang ; Lien, Wen Pin. / Left atrial appendage function determined by transesophageal echocardiography in patients with rheumatic mitral valve disease. In: Cardiology (Switzerland). 1994 ; Vol. 85, No. 2. pp. 121-128.
@article{57da0c3693c34160a517634497d87d50,
title = "Left atrial appendage function determined by transesophageal echocardiography in patients with rheumatic mitral valve disease",
abstract = "Left atrial thrombi have been considered to be the major source of systemic arterial embolization in patients with rheumatic mitral valve disease. Almost half of the left atrial thrombi are found in the left atrial appendage (LAA). To investigate LAA size and LAA contractile function in patients with rheumatic mitral valve disease, transesophageal echocardiographic and Doppler studies were performed in 61 patients. Among them, 46 patients were in atrial fibrillation (group 1), while the other 15 were in sinus rhythm (group 2). Thirty-six patients with nonrheumatic atrial fibrillation were chosen as control to group 1. Another 22 patients with various cardiovascular diseases and sinus rhythm served as control to group 2. When compared to the patients with nonrheumatic atrial fibrillation (control group), group 1 patients tended to have a larger LAA maximal area (9.7 ± 5.2 vs. 5.9 ± 2.8 cm2; p < 0.001). LAA ejection fraction and LAA peak emptying velocity were also lower. A significantly higher incidence of LAA spontaneous echo contrast (SEC) and thrombus formation was also found in these patients. Group 2 patients were also found to have a larger LAA maximal area when compared to the control group (8.8 ± 3.7 vs. 5.2 ± 3.0 cm2; p < 0.001). LAA ejection fraction and LAA peak emptying velocity were lower in this group, too. A higher incidence of LAA SEC formation was found in these patients with rheumatic mitral valve disease (4/15 vs. 0/22; p = 0.021). There was no significant difference, however, in LAA thrombus formation between group 2 and its control group (1/15 vs. 1/22; p = NS). Thus, patients with rheumatic mitral valve disease tend to have larger LAA size and poorer LAA contractile function. These promote the formation of LAA SEC and thrombus, especially when the patients have atrial fibrillation. Whether the poor LAA function predisposes these patients to future systemic arterial embolization still needs further investigation.",
keywords = "Left atrial appendage function, Rheumatic mitral valve disease, Transesophageal echocardiography",
author = "Hwang, {Juey Jen} and Li, {Yi Heng} and Lin, {Jer Ming} and Wang, {Tzong Luen} and Shyu, {Kou Gi} and Ko, {Yu Lin} and Lin, {Jiunn Lee} and Chen, {Jin Jer} and Peiliang Kuan and Lien, {Wen Pin}",
year = "1994",
month = "1",
day = "1",
doi = "10.1159/000176661",
language = "English",
volume = "85",
pages = "121--128",
journal = "Cardiology",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Left atrial appendage function determined by transesophageal echocardiography in patients with rheumatic mitral valve disease

AU - Hwang, Juey Jen

AU - Li, Yi Heng

AU - Lin, Jer Ming

AU - Wang, Tzong Luen

AU - Shyu, Kou Gi

AU - Ko, Yu Lin

AU - Lin, Jiunn Lee

AU - Chen, Jin Jer

AU - Kuan, Peiliang

AU - Lien, Wen Pin

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Left atrial thrombi have been considered to be the major source of systemic arterial embolization in patients with rheumatic mitral valve disease. Almost half of the left atrial thrombi are found in the left atrial appendage (LAA). To investigate LAA size and LAA contractile function in patients with rheumatic mitral valve disease, transesophageal echocardiographic and Doppler studies were performed in 61 patients. Among them, 46 patients were in atrial fibrillation (group 1), while the other 15 were in sinus rhythm (group 2). Thirty-six patients with nonrheumatic atrial fibrillation were chosen as control to group 1. Another 22 patients with various cardiovascular diseases and sinus rhythm served as control to group 2. When compared to the patients with nonrheumatic atrial fibrillation (control group), group 1 patients tended to have a larger LAA maximal area (9.7 ± 5.2 vs. 5.9 ± 2.8 cm2; p < 0.001). LAA ejection fraction and LAA peak emptying velocity were also lower. A significantly higher incidence of LAA spontaneous echo contrast (SEC) and thrombus formation was also found in these patients. Group 2 patients were also found to have a larger LAA maximal area when compared to the control group (8.8 ± 3.7 vs. 5.2 ± 3.0 cm2; p < 0.001). LAA ejection fraction and LAA peak emptying velocity were lower in this group, too. A higher incidence of LAA SEC formation was found in these patients with rheumatic mitral valve disease (4/15 vs. 0/22; p = 0.021). There was no significant difference, however, in LAA thrombus formation between group 2 and its control group (1/15 vs. 1/22; p = NS). Thus, patients with rheumatic mitral valve disease tend to have larger LAA size and poorer LAA contractile function. These promote the formation of LAA SEC and thrombus, especially when the patients have atrial fibrillation. Whether the poor LAA function predisposes these patients to future systemic arterial embolization still needs further investigation.

AB - Left atrial thrombi have been considered to be the major source of systemic arterial embolization in patients with rheumatic mitral valve disease. Almost half of the left atrial thrombi are found in the left atrial appendage (LAA). To investigate LAA size and LAA contractile function in patients with rheumatic mitral valve disease, transesophageal echocardiographic and Doppler studies were performed in 61 patients. Among them, 46 patients were in atrial fibrillation (group 1), while the other 15 were in sinus rhythm (group 2). Thirty-six patients with nonrheumatic atrial fibrillation were chosen as control to group 1. Another 22 patients with various cardiovascular diseases and sinus rhythm served as control to group 2. When compared to the patients with nonrheumatic atrial fibrillation (control group), group 1 patients tended to have a larger LAA maximal area (9.7 ± 5.2 vs. 5.9 ± 2.8 cm2; p < 0.001). LAA ejection fraction and LAA peak emptying velocity were also lower. A significantly higher incidence of LAA spontaneous echo contrast (SEC) and thrombus formation was also found in these patients. Group 2 patients were also found to have a larger LAA maximal area when compared to the control group (8.8 ± 3.7 vs. 5.2 ± 3.0 cm2; p < 0.001). LAA ejection fraction and LAA peak emptying velocity were lower in this group, too. A higher incidence of LAA SEC formation was found in these patients with rheumatic mitral valve disease (4/15 vs. 0/22; p = 0.021). There was no significant difference, however, in LAA thrombus formation between group 2 and its control group (1/15 vs. 1/22; p = NS). Thus, patients with rheumatic mitral valve disease tend to have larger LAA size and poorer LAA contractile function. These promote the formation of LAA SEC and thrombus, especially when the patients have atrial fibrillation. Whether the poor LAA function predisposes these patients to future systemic arterial embolization still needs further investigation.

KW - Left atrial appendage function

KW - Rheumatic mitral valve disease

KW - Transesophageal echocardiography

UR - http://www.scopus.com/inward/record.url?scp=0028120350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028120350&partnerID=8YFLogxK

U2 - 10.1159/000176661

DO - 10.1159/000176661

M3 - Article

C2 - 7954563

AN - SCOPUS:0028120350

VL - 85

SP - 121

EP - 128

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 2

ER -